Abstract
An imbalance in the redox state, increased levels of lipid precursors and overactivation of de novo lipogenesis determine the development of fibrosis during nonalcoholic steatohepatitis (NASH). We evaluated the modulation of NADPH-producing enzymes associated with the antifibrotic, antioxidant and antilipemic effects of nicotinamide (NAM) in a model of NASH induced by excess fructose consumption. Male rats were provided drinking water containing 40% fructose for 16 weeks. During the last 12 weeks of fructose administration, water containing NAM was provided to some of the rats for 5 h/day. The biochemical profiles and the ghrelin, leptin, lipoperoxidation and TNF-α levels in serum and the glucose-6-phosphate dehydrogenase (G6PD), malic enzyme (ME) and NADP+-dependent isocitric dehydrogenase (IDP) levels, the reduced/oxidized glutathione (GSH/GSSG) and reduced/oxidized nicotinamide adenine dinucleotide (phosphate) (NAD(P)H/NAD(P)+) ratios, and the levels of various lipogenic and fibrotic markers in the liver were evaluated. The results showed that hepatic fibrosis induced by fructose consumption was associated with weight gain, hunger-satiety system dysregulation, hyperinsulinemia, dyslipidemia, lipoperoxidation and inflammation. Moreover, increased levels of hepatic G6PD and ME activity and expression, the NAD(P)H/NAD(P)+ ratios, and GSSG concentration and increased expression of lipogenic and fibrotic markers were detected, and these alterations were attenuated by NAM administration. Specifically, NAM diminished the activity and expression of G6PD and ME, and this effect was associated with a decrease in the NADPH/NADP+ ratios, increased GSH levels and decreased lipoperoxidation and inflammation, ameliorating fibrosis and NASH development. NAM reduces liver steatosis and fibrosis by regulating redox homeostasis through a G6PD- and ME-dependent mechanism.
Similar content being viewed by others
References
Farzaei MH, Zobeiri M, Parvizi F, El-Senduny FF, Marmouzi I, Coy-Barrera E, Naseri R, Nabavi SM, Rahimi R, Abdollahi M (2018) Curcumin in liver diseases: a systematic review of the cellular mechanisms of oxidative stress and clinical perspective. Nutrients 10(7):1–28
Ramachandran P, Iredale JP (2012) Macrophagues: central regulators of hepatic fibrogenesis and fibrosis resolution. J Hepatol 56:1417–1419
Gendron MC, Schrantz N, Metivier D, Kroemer G, Maciorowska Z, Sureau F, Sureau F, Koester S, Petit PX (2001) Oxidation of pyridine nucleotides during Fas and ceramide-induced apoptosis in Jurkat cells correlation with changes in mitochondria, glutathione depletion, intracellular acidification and caspase 3 activation. J Biochem 353:357–367
Laliotis GP, Bizelis I, Rogdakis E (2010) Comparative approach of the novo fatty acid synthesis (Lipogenesis) between ruminant and non ruminant mammalian species: from biochemical level to the main regulatory lipogenic genes. Curr Genomics 1:168–183
Hecker PA, Lionetti V, Ribeiro RF, Rastogi S, Brown BH, O’Connell KA, Cox JW, Shekar KC, Gamble DM, Sabbah HN, Leopold JA, Gupte SA, Recchia FA, Stanley WC (2013) Glucose-6-phosphate dehydrogenase deficiency increases redox stress and moderately accelerates the development of heart failure. Circ Heart Fail 6:118–126
Kletzien RF, Harris PK, Foellmi LA (1994) Glucose-6-phosphate dehydrogenase: a housekeeping enzymes subject to tissue specific regulation by hormones, nutrients and oxidants stress. FASEB 8:174–181
Ferre P, Dentin R, Tomas-Cobos L, Foufelle F, Leopold J, Girard J, Postic C (2012) Glucose-6-phosphate dehydrogenase rather than xylulose-5-phosphate is required for the activation of ChREBP in response to glucose in the liver. J Hepatol 56:199–209
Torrres-Ramirez N, Baiza-Gutman LA, Garcia-Macedo R, Ortega-Camarillo C, Contreras-Ramos A, Medina-Navarro R, Cruz M, Ibáñez-Hernández MA, Díaz-Flores M (2013) Nicotinamide a glucose-6-phosphate dehydrogenase non-competitive mixed inhibitor, modifies redox balance and lipid accumulation in 3T3-cells. Life Sci 93:975–985
Angeles-Mejia S, Baiza-GutmanLA Ortega-Camarillo C, Medina-Navarro R, Sanchez-Becerra MC, Damasi-Santana L, Cruz M, Hernández-Pérez E, Díaz-Flores M (2018) Nicotinamide prevents sweet beverage-induced hepatic steatosis in rats by regulating the G6PD, NADPH/NADP+ and GSH/GSSG ratios and reducing oxidative and inflammatory stress. Eur J Pharmacol 818:499–507
Park JW, Lee SM, Koh HJ, Park DC, Song BJ, Huh TL (2002) Cytosolic NADP(+)-dependent isocitrate dehydrogenase status modulates oxidative damage to cells. Free Radic Biol Med 32(11):1185–1196
Koh HJ, Lee SM, Son BG, Lee SH, Ryoo ZY, Chang KT, Park JW, Park DC, Song BJ, Veech RL, Song H, Huh TL (2004) Cytosolic NADP+-dependent isocitrate dehydrogenase plays a key role in lipid metabolism. J Biol Chem 279:39968–39974
Pongratz RL, Kibbey RG, Shulman GI, Cline GW (2007) Cytosolic and mitochondrial malic enzyme isoforms differentially control insulin secretion. J Biol Chem 282:200–207
Rzezniczak TZ, Merritt TJ (2012) Interactions of NADP-reducing enzymes across varying environmental conditions: a model of biological complexity. G3: Genes G3(2):1613–1623
Basaranoglu M, Basaranoglu G, Sabuncu T, Sentürk H (2013) Fructose as a key player in the development of fatty liver disease. World J Gastroenterol 19:1166–1172
Ter Horst KW, Serlie MJ (2017) Fructose consumption, lipogenesis, and non-alcoholic fatty liver disease. Nutrients 9:1–20
Caton PW, Kieswich J, Yaqoob MM, Holness MJ, Sugden MC (2011) Nicotinamide mononucleotide protects against pro-inflammatory cytokine-mediated impairment of mouse islet function. Diabetologia 201(54):3083–3092
Shi Y, Zhang L, Jiang R, Chen W, Zheng W, Chen L, Tang L, Li L, Li L, Tang W, Wang Y, Yu Y (2012) Protective effects of nicotinamide against acetaminophen-induced acute liver injury. Int Immunopharmacol 14:530–537
Shibata K, Fukuwatari T, Suzuki C (2014) Pharmacological doses of nicotinic acid and nicotinamide are independently metabolized in rats. J Nutr Sci Vitaminol 60:86–93
Varela-Rey M, Martínez-López N, Fernández-Ramos D, Embade N, Calvisi DF, Woodhoo A, Rodríguez J, Fraga MF, Julve J, Rodríguez-Millán E, Frades I, Torres L, Luka Z, Wagner C, Esteller M, Lu SC, Martínez-Chantar ML, Mato JM (2010) Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide. Hepatology 52:105–114
Hecker PA, Mapanga RF, Kimar CP, Ribeiro RF Jr, Brown BH, O’Connell KA, Cox JW, Shekar KC, Asemu G, Essop MF, Stanley WC (2012) Effects of glucose-6-phosphate dehydrogenase deficiency on the metabolic and cardiac responses to obesogenic or high-fructose diets. Am J Physiol Endocrinol Metab 303:E959–E972
Wheeler MC, Tronconi MA, Drincovich MF, Andreo CS, Flügge UI, Maurino VG (2005) A comprehensive analysis of the NADP-malic enzyme gene family of Arabidopsis. Plant Physiol 139:39–51
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Tietze F (1969) Enzymatic method for quantitative determination of nanogram amounts of total anoxidized glutathione. Anal Biochem 27:502–522
Jentzsch AM, Bachmann H, Fürst P, Biesalski HK (1996) Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 20:251–256
Du L, Heaney AP (2012) Regulation of adipose differentiation by fructose and GluT5. Mol Endocrinol 26:773–1782
Kaser S, Dobner J, Ress C, Rufinatscha K, Salzmann K, Salvenmoser W, Folie S, Wieser V, Moser P, Weiss G, Goebel G, Tilg H, Kaser S (2017) Fat-enriched rather than high-fructose diets promote whitening of adipose tissue in a sex-dependent manner. J Nutr Biochem 49:22–29
Dekker MJ, Su Q, Baker C, Rutledge AC, Adeli K (2010) Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab 299:685–694
Teff KL, Elliott SS, Tschöp M, Kieffer TJ, Rader D, Heiman M, Townsend RR, Keim NL, D’Alessio D, Havel PJ (2004) Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab 89:2963–2972
Tillman EJ, Morgan DA, Rahmouni K, Swoap SJ (2014) Three months of high-fructose feeding fails to induce excessive weight gain or leptin resistance in mice. PLoS ONE 9:1–8
Villareal DT, Fontana L, Das SK, Redman L, Smith SR, Saltzman E, Bales C, Rochon J, Pieper C, Huang M, Lewis M, Schwartz AV (2016) Effect of two-year caloric restriction on bone metabolism and bone mineral density in non-obese younger adults: a randomized clinical trial. J Bone Miner Res 31:40–51
Pan WW, Myers MGJR (2018) Leptin and the maintenance of elevated body weight. Nat Rev Neurosci 19:95–105
Zhang SR, Fan XM (2015) Ghrelin-ghrelin O-acyltransferase system in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 21:3214–3222
Van Name M, Giannini C, Santoro N, Jastreboff AM, Kubat J, Li F, Kursawe R, Savoye M, Duran E, Dziura J, Sinha R, Sherwin RS, Cline G, Caprio S (2015) Blunted suppression of acyl-ghrelin in response to fructose ingestion in obese adolescents: the role of insulin resistance. Obesity (Silver Spring) 23:653–661
Liu J, Prudom CE, Nass R, Pezzoli SS, Oliveri MC, Johnson ML, Veldhuis P, Gordon DA, Howard AD, Witcher DR, Geysen HM, Gaylinn BD, Thorner MO (2008) Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men. J Clin Endocrinol Metab 93:1980–1987
Bursać BN, Djordjevic AD, Vasiljević AD, Milutinović DD, Veličković NA, Nestorović NM, Matić GM (2013) Fructose consumption enhances glucocorticoid action in rat visceral adipose tissue. J Nutr Biochem 24:1166–1172
Kovačević S, Nestorov J, Matić G, Elaković I (2014) Dietary fructose-related adiposity and glucocorticoid receptor function in visceral adipose tissue of female rats. Eur J Nutr 53:1409–1420
Yang G, Li C, Gong Y, Fang F, Tian H, Li J, Cheng X (2016) Assessment of insulin resistance in subjects with normal glucose tolerance, hyperinsulinemia with normal blood glucose tolerance, impaired glucose tolerance, and newly diagnosed type 2 diabetes (prediabetes insulin resistance research). J Diabetes Res 1:1–11
Sun RQ, Wang H, Zeng XY, Chan SM, Li SP, Jo E, Leung SL, Molero JC, Ye JM (2015) IRE1 impairs insulin signaling transduction of fructose-fed mice via JNK independent of excess lipid. Biochim Biophys Acta 1852:156–165
Shulman GI, Szendroedi J, Yoshimura T, Phielix E, Koliaki C, Marcucci M, Zhang D, Jelenik T, Müller J, Herder C, Nowotny P, Shulman GI, Roden M (2014) Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans. Proc Natl Acad Sci USA 111:9597–9602
Havel PJ, Elliott SS, Keim NL, Stern JS, Teff K (2002) Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 76:911–922
Kamada Y, Ono M, Hyogo H, Fujii H, Sumida Y, Yamada M, Mori K, Tanaka S, Maekawa T, Ebisutani Y, Yamamoto A, Takamatsu S, Yoneda M, Kawada N, Chayama K, Saibara T, Takehara T, Miyoshi E (2017) Use of Mac-2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis. Hepatol Commun 1:780–791
Boland ML, Oldham S, Boland BB, Will S, Lapointe JM, Guionaud S, Rhodes CJ, Trevaskis JL (2018) Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction. World J Gastroenterol 24:1748–1765
Fu S, Watkins SM, Hotamisligil GS (2012) The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling. Cell Metab 15:623–634
Ducker GS, Rabinowitz JD (2017) One-carbon metabolism in health and disease. Cell Metab 25:27–42
Fan J, Ye J, Kamphorst JJ, Shlomi T, Thompson CB, Rabinowitz JD (2014) Quantitative flux analysis reveals folate-dependent NADPH production. Nature 510:298–302
Varma V, Boros LG, Nolen GT, Chang CW, Wabitsch M, Beger RD, Kaput J (2015) Fructose alters intermediary metabolism of glucose in human adipocytes and diverts glucose to serine oxidation in the one-carbon cycle energy producing pathway. Metabolites 5(2):364–385
Sorbi D, Boynton J, Lindor KD (1999) The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 94:1018–1022
Verma S, Jensen D, Hart J, Mohanty SR (2013) Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Liver Int 33:1398–1405
Pogribny IP, Kutanzi K, Melnyk S, de Conti A, Tryndyak V, Montgomery B, Pogribna M, Muskhelishvili L, Latendresse JR, James SJ, Beland FA, Rusyn I (2013) Strain-dependent dysregulation of one-carbon metabolism in male mice is associated with choline- and folate-deficient diet-induced liver injury. FASEB J 27(6):2233–2243
Schafer FQ, Buettner GR (2001) Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30:1191–1212
Mailloux RJ, Treberg JR (2016) Protein S-glutathionlyation links energy metabolism to redox signaling in mitochondria. Redox Biol 8:110–118
Dou X, Li S, Hu L, Ding L, Ma Y, Ma W, Chai H, Song Z (2018) Glutathione disulfide sensitizes hepatocytes to TNFα-mediated cytotoxicity via IKK-β S-glutathionylation: a potential mechanism underlying non-alcoholic fatty liver disease. Exp Mol Med 50:1–7
Piemonte F, Petrini S, Gaeta LM, Tozzi G, Bertini E, Devito R, Boldrini R, Marcellini M, Ciacco E, Nobili V (2008) Protein glutathionylation increases in the liver of patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 23:457–464
Salati LM, Amir-Ahmady B (2001) Dietary regulation of expression of glucose-6-phosphate dehydrogenase. Annu Rev Nutr 21:121–140
Janevski M, Ratnayake S, Siljanovski S, McGlynn MA, Cameron-Smith D, Lewandowski P (2012) Fructose containing sugars modulate mRNA of lipogenic genes ACC and FAS and protein levels of transcription factors ChREBP and SREBP1c with no effect on body weight or liver fat. Food Funct 3:141–149
Herman MA, Samuel VT (2016) The sweet path to metabolic demise: fructose and lipid synthesis. Trends Endocrinol Metab 27:719–730
Mastrocola R, Nigro D, Chiazza F, Medana C, Dal Bello F, Boccuzzi G, Collino M, Aragno M (2016) Fructose-derived advanced glycation end-products drive lipogenesis and skeletal muscle reprogramming via SREBP-1c dysregulation in mice. Free Radic Biol Med 91:224–235
Iizuka K (2017) The role of carbohydrate response element binding protein in intestinal and hepatic fructose metabolism. Nutrients 9:1–12
Novo E, Marra F, Zamara E, Valfrè di Bonzo L, Caligiuri A, Cannito S, Antonaci C, Colombatto S, Pinzani M, Parola M (2006) Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells. Gut 55:90–97
Friedman SL (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134:1655–1669
Kavanagh K, Cydylo MA, Davis AT (2017) Fatty liver promotes fibrosis in monkeys consuming high fructose. Obesity 25:290–293
Rector RS, Panasevich MR, Meers GM, Linden MA, Perfield JW, Fritsche KL, Wankhade UD, Chintapalli SV, Shankar K, Ibdah JA (2018) High-fat, high-fructose, high-cholesterol feeding causes severe NASH and cecal microbiota dysbiosis in juvenile Ossabaw swine. Am J Physiol Endocrinol Metab 314:78–92
Xie XW (2017) Liquiritigenin attenuates cardiac injury induced by high fructose-feeding through fibrosis and inflammation suppression. Biomed Pharmacother 86:694–704
Schöndorf DC, Ivanyuk D, Baden P, Sanchez-Martinez A, De Cicco S, Yu C, Giunta I, Schwarz LK, Di Napoli G, Panagiotakopoulou V, Nestel S, Keatinge M, Pruszak J, Bandmann O, Heimrich B, Gasser T, Whitworth AJ, Deleidi M (2018) The NAD+ precursor nicotinamide riboside rescues mitochondrial defects and neuronal loss in iPSC and fly models of parkinson’s disease. Cell Rep 23:2976–2988
Khan NA, Auranen M, Paetau I, Pirinen E, Euro L, Forsström S, Pasila L, Velagapudi V, Carroll CJ, Auwerx J, Suomalainen A (2014) Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. MBO Mol Med 6:721–731
Yang SJ, Choi JM, Kim L, Park SE, Rhee EJ, Lee WY, Oh KW, Park SW, Park CY (2014) Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes. J Nutr Biochem 25:66–72
Jang SY, Kang HT, Hwang ES (2012) Nicotinamide-induced mitophagy: event mediated by high NAD+/NADH ratio and SIRT1 protein activation. J Biol Chem 287:19304–19314
Acknowledgements
The authors gratefully acknowledge the assistance provided by Dra. Mariela Sánchez Claudio. This research study was funded by Fomento de Investigación en Salud, Instituto Mexicano del Seguro Social (FIS/IMSS/PROT/G15/1424 and FIS/IMSS/PROT/MD/17/1685) and CONACYT (Scholarship 262758).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors of this research declare that there are no conflicts of any kind.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Loza-Medrano, S.S., Baiza-Gutman, L.A., Manuel-Apolinar, L. et al. High fructose-containing drinking water-induced steatohepatitis in rats is prevented by the nicotinamide-mediated modulation of redox homeostasis and NADPH-producing enzymes. Mol Biol Rep 47, 337–351 (2020). https://doi.org/10.1007/s11033-019-05136-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-019-05136-4